Research & Development

Is PLX-R18 the Future of Nuclear Radiation Therapy?
Research & Development Is PLX-R18 the Future of Nuclear Radiation Therapy?

In the rapidly advancing field of nuclear radiation therapy, a groundbreaking treatment is emerging, promising to redefine the landscape of medical response to nuclear events. Financed by the backing of a weighty $4.2 million agreement with the National Institute of Allergy and Infectious Diseases

How Will AI Revolutionize Drug Discovery for Hoth Therapeutics?
Research & Development How Will AI Revolutionize Drug Discovery for Hoth Therapeutics?

In the fast-evolving landscape of biopharmaceuticals, innovative approaches to drug discovery signal a transformative era for companies like Hoth Therapeutics Inc. A strategic partnership with Wise Systems International SRL marks the beginning of an ambitious journey to incorporate artificial

Is the DEA Blocking Progress in Cannabis Medical Research?
Research & Development Is the DEA Blocking Progress in Cannabis Medical Research?

As the field of medical research forges ahead, certain pioneering companies are facing a formidable hurdle. MMJ BioPharma Labs and MMJ International Holdings, at the forefront of developing cannabis-based pharmaceuticals, find themselves entangled in a problematic scenario with the Drug Enforcement

Unlocking Cancer's Foe: The Power of CD8-fit T Cells
Research & Development Unlocking Cancer's Foe: The Power of CD8-fit T Cells

Cancer treatments have long been a complex array of procedures with varying degrees of success. However, groundbreaking research from the University of Houston, spearheaded by Navin Varadarajan and his team, has shone a light on a new horizon for cancer therapy. They have identified CD8-fit T

How Will Peptide Backbone Tweaks Revolutionize Drug Discovery?
Research & Development How Will Peptide Backbone Tweaks Revolutionize Drug Discovery?

Despite tremendous advancements in medical science, drug discovery remains a daunting challenge, particularly when it comes to illnesses involving complex protein interactions. Conventional drug development strategies fall short when faced with the vast network of protein-protein interactions

Asthma Treatments Expand with 90+ Pipelines by Global Firms
Research & Development Asthma Treatments Expand with 90+ Pipelines by Global Firms

As we witness a demanding push for the development of innovative asthma treatments, over 80 key companies globally have embarked on an ambitious journey. This initiative aims to create a robust arsenal of more than 90 therapeutic approaches, targeting a condition that continues to affect the

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later